| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $238 | 1 | 33 |
Sells | $241 | 2 | 67 |
| Jin David | director | 1 | $238 | 0 | $0 | $238 |
| Chill Adam J. | director | 0 | $0 | 1 | $4 | $-4 |
| Herskowitz Neil | director | 0 | $0 | 1 | $238 | $-238 |
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapies for blastic plasmacytoid dendritic cell neoplasm, acute myeloid leukemia, and myelodysplastic syndrome; MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-104 CAR T for multiple myeloma and light chain amyloidosis; MB-101 CAR T cell program for glioblastoma; MB-103 CAR T for glioblastoma multiforme (GBM) and metastatic breast cancer to brain; MB-105 CAR T for prostate and pancreatic cancers; and MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clin Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH, and Minaris Regenerative Medicine GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Over the last 12 months, insiders at Mustang Bio, Inc. have bought $238 and sold $241 worth of Mustang Bio, Inc. stock.
On average, over the past 5 years, insiders at Mustang Bio, Inc. have bought $136,194 and sold $13,267 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Jin David (director) — $238.
The last purchase of 247 shares for transaction amount of $238 was made by Jin David (director) on 2025‑12‑30.
| 2025-12-30 | Sale | Chill Adam J. | director | 4 <0.0001% | $0.95 | $4 | +4.93% | |
| 2025-12-30 | Sale | Herskowitz Neil | director | 247 0.0034% | $0.96 | $238 | +4.93% | |
| 2025-12-30 | Jin David | director | 247 0.0034% | $0.96 | $238 | +4.93% | ||
| 2022-09-13 | Litchman Manuel MD | director | 5,000 0.0041% | $0.52 | $2,582 | -30.68% | ||
| 2022-09-13 | ROSENWALD LINDSAY A MD | director | 5,000 0.0041% | $0.52 | $2,582 | -30.68% | ||
| 2022-03-18 | Litchman Manuel MD | director | 5,000 0.0041% | $0.74 | $3,695 | -34.11% | ||
| 2022-03-18 | ROSENWALD LINDSAY A MD | director | 4,094 0.0034% | $0.74 | $3,025 | -34.11% | ||
| 2021-12-14 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 4,374 0.0003% | $1.83 | $8,004 | -62.80% | |
| 2021-10-27 | Litchman Manuel MD | President and CEO | 65,000 0.0048% | $2.24 | $145,600 | -65.88% | ||
| 2021-10-12 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 4,450 0.0003% | $2.28 | $10,146 | -64.93% | |
| 2021-07-30 | Litchman Manuel MD | President and CEO | 86,206 0.0063% | $2.91 | $250,859 | -59.52% | ||
| 2021-04-09 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 2,423 0.0002% | $3.36 | $8,141 | -22.88% | |
| 2021-03-05 | Litchman Manuel MD | President and CEO | 165,562 0.0135% | $3.12 | $516,553 | -12.46% | ||
| 2020-12-15 | Litchman Manuel MD | President and CEO | 100,000 0.0114% | $2.91 | $291,000 | +2.69% | ||
| 2020-12-14 | ROSENWALD LINDSAY A MD | director | 100,000 0.0115% | $2.66 | $266,000 | +12.96% | ||
| 2020-12-08 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 5,185 0.0006% | $3.03 | $15,711 | -1.29% | |
| 2020-10-21 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 3,056 0.0004% | $2.97 | $9,076 | +11.39% | |
| 2020-06-11 | Litchman Manuel MD | President and CEO | 153,846 0.0228% | $3.25 | $500,000 | +0.15% | ||
| 2020-05-22 | Sale | Litchman Manuel MD | President and CEO | 12,373 0.0018% | $3.04 | $37,614 | +5.84% | |
| 2020-05-22 | Sale | Achenbach Brian | SVP, Fin. & Corp. Controller | 880 0.0001% | $3.04 | $2,675 | +5.84% |
| Chill Adam J. | director | 375 0.0051% | $336.11 | 0 | 1 | |
| Jin David | director | 286 0.0039% | $256.34 | 1 | 0 | |
| Herskowitz Neil | director | 145 0.002% | $129.96 | 1 | 1 | |
| Litchman Manuel MD | director | 1098987 15.0565% | $985,022.05 | 14 | 1 | +1.42% |
| ROSENWALD LINDSAY A MD | director | 299181 4.0989% | $268,155.93 | 4 | 0 | +12.96% |
| Achenbach Brian | SVP, Fin. & Corp. Controller | 144729 1.9828% | $129,720.60 | 3 | 8 |
$13,664,154 | 40 | -70.35% | $6.22M | |
$1,029,337 | 36 | -28.38% | $7.83M | |
$29,635,355 | 27 | 9.05% | $5.68M | |
$63,749,694 | 24 | -12.24% | $8.06M | |
$1,039,491 | 21 | -11.76% | $6.84M | |
$742,412 | 14 | -50.36% | $5.93M | |
$684,058 | 11 | -57.59% | $5.1M | |
$188,726 | 11 | -28.87% | $8.17M | |
$405,510 | 11 | -46.23% | $6.41M | |
$120,379 | 10 | -24.48% | $7.28M | |
$8,971,546 | 8 | 6.18% | $5.37M | |
$211,895 | 8 | -39.70% | $7.03M | |
$159,974 | 7 | -18.60% | $6.45M | |
$76,299 | 4 | 11.60% | $4.98M | |
$1,184,658 | 4 | -22.17% | $7.38M | |
Mustang Bio, Inc. (MBIO) | $1,057,000 | 3 | 5.27% | $6.54M |
$28,395 | 3 | 3.48% | $7.97M | |
$31,190 | 2 | -14.18% | $6.9M | |
$4,423 | 2 | 3.27% | $4.85M |
| Increased Positions | 12 | +57.14% | 284,301 | +101.31% |
| Decreased Positions | 6 | -28.57% | 12,981 | -4.63% |
| New Positions | 6 | New | 225,698 | New |
| Sold Out Positions | 3 | Sold Out | 12,431 | Sold Out |
| Total Postitions | 27 | +28.57% | 551,955 | +96.68% |
| Blackrock, Inc. | $91.00 | 1.41% | 84,745 | +83,080 | +4,989.79% | 2025-09-30 |
| Kestra Advisory Services, Llc | $71.00 | 1.1% | 66,108 | +66,108 | New | 2025-09-30 |
| Vanguard Group Inc | $62.00 | 0.96% | 57,863 | +57,863 | New | 2025-09-30 |
| Geode Capital Management, Llc | $28.00 | 0.44% | 26,418 | +10,336 | +64.27% | 2025-09-30 |
| Xtx Topco Ltd | $20.00 | 0.31% | 18,775 | +18,775 | New | 2025-09-30 |
| Renaissance Technologies Llc | $13.00 | 0.2% | 11,800 | +11,800 | New | 2025-09-30 |
| Cfo4life Group, Llc | $11.00 | 0.17% | 10,461 | +10,461 | New | 2025-09-30 |
| Sbi Securities Co., Ltd. | $2.00 | 0.03% | 2,007 | +1,505 | +299.8% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.02% | 1,332 | -2,646 | -66.52% | 2025-09-30 |
| Citigroup Inc | $1.00 | 0.01% | 602 | -404 | -40.16% | 2025-09-30 |